HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia - Wikidata - wikimedia - TriplyDB

HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia

HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia

http://www.wikidata.org/entity/Q36403983

about

Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26 Regulation of neutrophil function by adenosine.Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery Hypoxia-inducible factors as molecular targets for liver diseases Attenuating myocardial ischemia by targeting A2B adenosine receptors The clinically relevant pharmacogenomic changes in acute myelogenous leukemia EGL-9 controls C. elegans host defense specificity through prolyl hydroxylation-dependent and -independent HIF-1 pathways Molecular mechanisms of ischemic preconditioning in the kidney The reno-vascular A2B adenosine receptor protects the kidney from ischemia Adenosine receptors as drug targets--what are the challenges?Equilibrative nucleoside transporters-A review.Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis.Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival.Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia.Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection.Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo.Adenosine: an old drug newly discovered.Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones Excess adenosine A2B receptor signaling contributes to priapism through HIF-1α mediated reduction of PDE5 gene expression The adenosine transporter, ENT1, in cardiomyocytes is sensitive to inhibition by ethanol in a kinase-dependent manner: implications for ethanol-dependent cardioprotection and nucleoside analog drug cytotoxicity.Hypoxia-induced deoxycytidine kinase expression contributes to apoptosis in chronic lung disease.Identification of vasodilator-stimulated phosphoprotein (VASP) as an HIF-regulated tissue permeability factor during hypoxia Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation Signalling pathways involved in hypoxia-induced renal fibrosis.Protection against acute kidney injury via A(1) adenosine receptor-mediated Akt activation reduces liver injury after liver ischemia and reperfusion in mice.Partial netrin-1 deficiency aggravates acute kidney injury Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement Hypoxia signaling controls postnatal changes in cardiac mitochondrial morphology and function.Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface.Extracellular nucleotide and nucleoside signaling in vascular and blood disease Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres HIF-1 regulates iron homeostasis in Caenorhabditis elegans by activation and inhibition of genes involved in iron uptake and storage Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammation 2,3,7,8-Tetrachlorodibenzo-p-dioxin induced cell-specific drug transporters with acquired cisplatin resistance in cisplatin sensitive cancer cells.Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations The resurgence of A2B adenosine receptor signaling Decreased extracellular adenosine levels lead to loss of hypoxia-induced neuroprotection after repeated episodes of exposure to hypoxia.Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases

P2860

Q24323818-685C4ADB-46F4-430B-B5D5-5C8C300F70B4 Q24620317-24110249-39FA-4CCD-B35D-94DA0038F331 Q24620924-53B48F74-057F-4232-85F3-357692C7D72D Q26752304-9B386659-DD82-4CD8-A817-BB515BBDC0DE Q27006863-0A1F6E00-25C2-4E6A-B13E-94D6E0C3D456 Q27014790-9DC556A2-E7B7-4108-873B-CE78FEB64118 Q27343881-DE7BDAC9-FB78-42C9-A717-F4205A14E74E Q28080772-BB53729E-8491-42F2-8113-3F16061A62F4 Q28473410-AAE3B796-463D-4488-8719-708015C40224 Q29346491-26055222-C480-4C44-BAC8-2DA41FC38217 Q30244329-5E849913-D0DC-47DC-BAE9-E079C8309A7F Q30881980-D792A7A7-866F-4523-9C4F-B7F54C509272 Q33297014-E4376CC3-2A0B-4CB0-AF35-60BD828F9F13 Q33312383-26BA24FB-4B7A-4E68-877F-D1573FA67F46 Q33356018-85004ABC-A9FC-45C3-89F4-7D81EA5B9FC0 Q33374284-B9967FCB-7DE5-4A81-8A86-B322F8688410 Q33496725-442AE6D7-7FAD-42F5-AAA2-FF13DD4B4C07 Q33555006-2466DAFE-A845-4468-9FD4-0DF1E24D5311 Q33569829-7D46CB5A-214A-44DE-8410-C41647FA92F1 Q33613207-73EB1603-86F4-407A-99D0-C6D43D116FF1 Q33692620-59D93C98-7C70-4537-BF3D-6C23DFFCF650 Q33713383-B9C7316F-89CC-43C4-8F68-0CB3370E16DD Q33725755-1E9DF28B-D234-4BA8-9145-7A937EE5A0DA Q33807056-874AAFF3-523D-4BE0-8574-6EAF63ABBFF8 Q33830064-399493CE-439C-40B0-8BF3-E1B91245DA82 Q33844658-CBCAA6FA-29FD-42C3-A986-EB8CA1A28EB6 Q33890909-E505C24E-1EF8-4670-8171-C587C1821AD8 Q33916670-6E2FE89E-B819-40EF-AFFF-518B813B6019 Q33916975-0C7ADC24-DC27-4299-83CA-E0B66C2C283C Q34001111-EFAEFEB7-6BCB-47EE-912E-BE1B27C3C0D4 Q34011327-981A6C3C-7D98-4407-A05B-D9AFC37496AE Q34047834-114CB514-CE81-4F14-8E31-98907E0FD86C Q34087018-26F531EC-9DFC-43F2-BC95-D8403091BB3E Q34109802-9A62B275-E6B9-4CC0-BD81-F4EA3419743A Q34184568-4204F170-EAE4-4463-879B-44BAE5ADE9D6 Q34208237-198B6900-884B-4AB4-8A1F-FB2983B69932 Q34211096-93EBE764-A42D-4021-B7FE-039133A8D050 Q34307284-444E2FD1-2696-4ECC-9487-8EB03DD63140 Q34599971-7F9FC01E-C62D-45C3-ADF5-5AB02E6BB42F Q34657382-40A4E1CF-F9CF-49F9-A7C2-A7617D60EFE8

P2860

HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia

http://www.wikidata.org/entity/Q36403983

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia

@ast

HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia

@en

type

label

HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia

@ast

HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia

@en

prefLabel

HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia

@ast

HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia

@en

P1433

Q36403983-BE6765ED-B132-4AE5-877D-43FE1E21D9DC

P1476

Q36403983-0CD7E8D2-BE73-4490-B2FD-A5866F7910B3

P2093

Q36403983-0871392D-C327-4905-B674-054626251523

Q36403983-12E55DA9-ABA3-4B46-81D5-0E1488F75186

Q36403983-15CD61EF-DD67-47F0-BF06-C6D1286BC1BE

Q36403983-4A637DD4-E98A-4FEB-88EC-3963598CD047

Q36403983-591A9BB6-1DFF-4C6E-B681-F26CC9E6645C

Q36403983-6A3C4727-7CE6-4739-A5B6-0289163BCD6F

Q36403983-6E2FDBBA-990B-4282-AB3E-CB8788EF98C7

Q36403983-81810CCF-838D-449D-B074-C7C302AE1D46

Q36403983-935C8D01-BCB7-42E0-B5D1-D2865CD2B200

Q36403983-9B73E1B7-F9BF-43FB-AFD8-9CED107C30CB

P2860

Q36403983-00BA2CB8-8CF3-4A8A-9DCF-D75DCA031506

Q36403983-08C050F4-BA38-4D8A-9E71-AF650921E121

Q36403983-0D3F39F0-CDFD-4D91-AB0B-C715F70D9ECB

Q36403983-1A72A81D-A28E-414F-AF99-D216F21A16A4

Q36403983-23BB2D01-4A3E-4A01-8201-9A17E131919A

Q36403983-2519AB01-E522-4F38-A121-7946B53D56FF

Q36403983-2AC2C1E9-F341-48D2-B08F-B0B45432059D

Q36403983-2B4FE948-2606-42BE-8337-B753E3CD2C34

Q36403983-2F21B9E4-5D54-4CF3-9C6F-5759F34CBAB1

Q36403983-35D0754D-711D-435C-8348-608294AACB05

P304

Q36403983-82954F7C-1A90-4ABE-A537-3B9807A774ED

P31

Q36403983-9BDE3DCB-C351-4725-A117-177568480A98

P356

Q36403983-D681D6D7-6CE6-4617-BEE8-DDEB29F87ABE

P407

Q36403983-30D82226-38CC-4DAB-B854-5B83AA03BF2E

P433

Q36403983-4C940B74-906C-4868-98FF-D5F868539E13

P478

Q36403983-3927823E-1990-4C70-985C-089669B03C46

P577

Q36403983-1085F650-C086-4900-9B39-BA4CFBEB6F69

P5875

Q36403983-84E6BA82-1992-4516-A708-D44FA94E371F

P698

Q36403983-668A1E39-4CC3-46C9-BD73-5C16A4F40E4A

P921

Q36403983-6A1880FF-D343-4A0F-A424-958F19865F14

P932

Q36403983-8B904D22-2E3E-47A5-AA34-9C694F71D4C9

P356

P1433

Journal of Experimental Medicine

P1476

HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia

@en

P2093

Andreas Robinson

http://www.w3.org/2001/XMLSchema#string

Caroline Schönfeld

http://www.w3.org/2001/XMLSchema#string

Dionne Daniels

http://www.w3.org/2001/XMLSchema#string

Edgar Hoffman

http://www.w3.org/2001/XMLSchema#string

German Reyes

http://www.w3.org/2001/XMLSchema#string

Holger K Eltzschig

http://www.w3.org/2001/XMLSchema#string

Imogen R Coe

http://www.w3.org/2001/XMLSchema#string

Jorn Karhausen

http://www.w3.org/2001/XMLSchema#string

Karen A Westerman

http://www.w3.org/2001/XMLSchema#string

Kathryn E Hamilton

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors

Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia.

A new mathematical model for relative quantification in real-time RT-PCR

The equilibrative nucleoside transporter family, SLC29

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells

Oxygen sensing by HIF hydroxylases

Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection.

P304

1493-1505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20050177

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7438432

http://www.w3.org/2001/XMLSchema#string

P698

16330813

http://www.w3.org/2001/XMLSchema#string

P921

P932

2213326

http://www.w3.org/2001/XMLSchema#string